chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Product dose omission issue, Vaccination site pain
Clinical narrative: Patient missed 2nd dose of Moderna COVID-19 vaccine; Sore arm 3 weeks after 1st dose; Injection site felt like a punch 3 weeks after 1st dose; Arm feels a little bit sore; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient missed 2nd dose of Moderna COVID-19 vaccine), PAIN IN EXTREMITY (Sore arm 3 weeks after 1st dose), PAIN IN EXTREMITY (Arm feels a little bit sore) and VACCINATION SITE PAIN (Injection site felt like a punch 3 weeks after 1st dose) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ALPRAZOLAM (XANAX) and TRAZODONE for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm feels a little bit sore). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient missed 2nd dose of Moderna COVID-19 vaccine), PAIN IN EXTREMITY (Sore arm 3 weeks after 1st dose) and VACCINATION SITE PAIN (Injection site felt like a punch 3 weeks after 1st dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient missed 2nd dose of Moderna COVID-19 vaccine), PAIN IN EXTREMITY (Sore arm 3 weeks after 1st dose), PAIN IN EXTREMITY (Arm feels a little bit sore) and VACCINATION SITE PAIN (Injection site felt like a punch 3 weeks after 1st dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information provided.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Pruritus
Clinical narrative: Itchiness; Redness; Pain and Soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain and Soreness), PRURITUS (Itchiness) and ERYTHEMA (Redness) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced PAIN (Pain and Soreness). On 25-Apr-2021, the patient experienced PRURITUS (Itchiness) and ERYTHEMA (Redness). The patient was treated with Manual therapy (ice patch) for Pruritus. At the time of the report, PAIN (Pain and Soreness), PRURITUS (Itchiness) and ERYTHEMA (Redness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Patient was treated with Ice Patch.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Pyrexia, SARS-CoV-2 test, Sinus disorder
Clinical narrative: Diagnosed with Covid-19; Sinus discomfort; fever; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed with Covid-19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced COVID-19 (Diagnosed with Covid-19) (seriousness criterion medically significant), SINUS DISORDER (Sinus discomfort) and PYREXIA (fever). On 26-Apr-2021, SINUS DISORDER (Sinus discomfort) and PYREXIA (fever) had resolved. At the time of the report, COVID-19 (Diagnosed with Covid-19) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Apr-2021, SARS-CoV-2 test positive: (abnormal) HCP diagnosed patient with Covid-19, as test results were positive..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications reported.  Description: The patient was currently in quarantine status and would be until 03 May 2021. SARS-COV-2 TEST POSITIVE (diagnosed with Covid-19).  No treatment information provided.  Company comment: Based on biological implausibility the event of COVID-19 infection is assessed as unlikely related to mRNA-1273. Additionally reported sinus discomfort and fever were assessed as symptoms of COVID-19 infection thus also unlikely related.; Sender's Comments: Based on biological implausibility the event of COVID-19 infection is assessed as unlikely related to mRNA-1273. Additionally reported sinus discomfort and fever were assessed as symptoms of COVID-19 infection thus also unlikely related.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain
Clinical narrative: soreness; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness) and ARTHRALGIA (joint pain) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     The patient's past medical history included MS (Multiple sclerosis).    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (soreness) and ARTHRALGIA (joint pain). At the time of the report, PAIN (soreness) and ARTHRALGIA (joint pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  Treatment information was not provided    This case was linked to MODERNATX, INC.-MOD-2021-090483 (E2B Linked Report).; Sender's Comments: MODERNATX, INC.-MOD-2021-090483:crosslinked dose 2
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Dermatitis contact, Herpes zoster
Clinical narrative: poison Ivy eruption on her face; shingles; This spontaneous case was reported by a consumer and describes the occurrence of DERMATITIS CONTACT (poison Ivy eruption on her face) and HERPES ZOSTER (shingles) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DERMATITIS CONTACT (poison Ivy eruption on her face) and HERPES ZOSTER (shingles). At the time of the report, DERMATITIS CONTACT (poison Ivy eruption on her face) and HERPES ZOSTER (shingles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided. Treatment information was not provided.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Contusion, Gait disturbance, International normalised ratio, Mobility decreased, Pain in extremity
Clinical narrative: Bruising/ Entire leg turning black and blue; Could not bend/ could not put pressure on leg; swollen leg; Trouble walking; knee issues and leg pain/rt leg started to ache/ache got worse and pain intensified/ tender to touch; Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (knee issues and leg pain/rt leg started to ache/ache got worse and pain intensified/ tender to touch), MOBILITY DECREASED (Could not bend/ could not put pressure on leg), GAIT DISTURBANCE (Trouble walking), PERIPHERAL SWELLING (swollen leg) and CONTUSION (Bruising/ Entire leg turning black and blue) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stroke on 27-Jun-2017. Concurrent medical conditions included Latex allergy and Drug allergy (Lipitor). Concomitant products included WARFARIN SODIUM (COUMADIN) from 29-Jun-2017 to an unknown date and ROSUVASTATIN from 29-Jun-2017 to an unknown date for Stroke, ROSUVASTATIN CALCIUM (CRESTOR), VITAMINS NOS (DAILY MULTIVITAMIN), GLUCOSAMINE and ZINC for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In March 2021, the patient experienced PAIN IN EXTREMITY (knee issues and leg pain/rt leg started to ache/ache got worse and pain intensified/ tender to touch) and PAIN IN EXTREMITY (Arm soreness). In April 2021, the patient experienced GAIT DISTURBANCE (Trouble walking). On 16-Apr-2021, the patient experienced MOBILITY DECREASED (Could not bend/ could not put pressure on leg) and PERIPHERAL SWELLING (swollen leg). On 22-Apr-2021, the patient experienced CONTUSION (Bruising/ Entire leg turning black and blue). At the time of the report, PAIN IN EXTREMITY (knee issues and leg pain/rt leg started to ache/ache got worse and pain intensified/ tender to touch), PERIPHERAL SWELLING (swollen leg) and CONTUSION (Bruising/ Entire leg turning black and blue) was resolving and MOBILITY DECREASED (Could not bend/ could not put pressure on leg), GAIT DISTURBANCE (Trouble walking) and PAIN IN EXTREMITY (Arm soreness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Mar-2021, International normalised ratio: 3.1 (High) shoots up. On 21-Apr-2021, International normalised ratio: 3.23 (High) high.         No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Significant follow-up: Patient demographics ,concomitant mediation, relevant history ,allergies were added.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Bruising/ Entire leg turning black and blue; Could not bend/ could not put pressure on leg; swollen leg; Trouble walking; knee issues and leg pain/rt leg started to ache/ache got worse and pain intensified/ tender to touch; Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (knee issues and leg pain/rt leg started to ache/ache got worse and pain intensified/ tender to touch), MOBILITY DECREASED (Could not bend/ could not put pressure on leg), GAIT DISTURBANCE (Trouble walking), PERIPHERAL SWELLING (swollen leg) and CONTUSION (Bruising/ Entire leg turning black and blue) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stroke on 27-Jun-2017. Concurrent medical conditions included Latex allergy and Drug allergy (Lipitor). Concomitant products included WARFARIN SODIUM (COUMADIN) from 29-Jun-2017 to an unknown date and ROSUVASTATIN from 29-Jun-2017 to an unknown date for Stroke, ROSUVASTATIN CALCIUM (CRESTOR), VITAMINS NOS (DAILY MULTIVITAMIN), GLUCOSAMINE and ZINC for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In March 2021, the patient experienced PAIN IN EXTREMITY (knee issues and leg pain/rt leg started to ache/ache got worse and pain intensified/ tender to touch) and PAIN IN EXTREMITY (Arm soreness). In April 2021, the patient experienced GAIT DISTURBANCE (Trouble walking). On 16-Apr-2021, the patient experienced MOBILITY DECREASED (Could not bend/ could not put pressure on leg) and PERIPHERAL SWELLING (swollen leg). On 22-Apr-2021, the patient experienced CONTUSION (Bruising/ Entire leg turning black and blue). At the time of the report, PAIN IN EXTREMITY (knee issues and leg pain/rt leg started to ache/ache got worse and pain intensified/ tender to touch), PERIPHERAL SWELLING (swollen leg) and CONTUSION (Bruising/ Entire leg turning black and blue) was resolving and MOBILITY DECREASED (Could not bend/ could not put pressure on leg), GAIT DISTURBANCE (Trouble walking) and PAIN IN EXTREMITY (Arm soreness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Mar-2021, International normalised ratio: 3.1 (High) shoots up. On 21-Apr-2021, International normalised ratio: 3.23 (High) high.         No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Significant follow-up: Patient demographics ,concomitant mediation, relevant history ,allergies were added.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: redness after the second dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness after the second dose) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness after the second dose). At the time of the report, VACCINATION SITE ERYTHEMA (redness after the second dose) outcome was unknown.            No concomitant products and treatment medication were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-090449 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-090449:Husband 2nd Dose
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Heart rate, Hypertension, Palpitations
Clinical narrative: Rapid heart beat which went upto 165bpm; Raised blood pressure upto 149/89; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Rapid heart beat which went upto 165bpm) and HYPERTENSION (Raised blood pressure upto 149/89) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced PALPITATIONS (Rapid heart beat which went upto 165bpm) and HYPERTENSION (Raised blood pressure upto 149/89). At the time of the report, PALPITATIONS (Rapid heart beat which went upto 165bpm) and HYPERTENSION (Raised blood pressure upto 149/89) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 148/89 (High) 148/89. On an unknown date, Heart rate: 165 (High) 165 bpm.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product details was not reported.  Treatment details was not reported .   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Contracted COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Contracted COVID) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced COVID-19 (Contracted COVID). At the time of the report, COVID-19 (Contracted COVID) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  No treatment details were provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-090432 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-090432:
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Pruritus
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pruritus (itching for one hour) and increased heart rate (racing heartbeat) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 017B21A) for COVID-19 immunization. No medical history reported. On Apr 1, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), intramuscular; 1 dosage form. On Apr 1, 2021, patient experienced pruritus (itching for one hour) and increased heart rate (racing heartbeat). On Apr 1, 2021, pruritus (itching for one hour) and increased heart rate (racing heartbeat) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information provided.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Malaise, Nausea, Productive cough, Pyrexia
Clinical narrative: productive cough; feeling completely sick; Diagnosed with Covid-19; Fever; nausea; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COVID-19 (Diagnosed with Covid-19), PRODUCTIVE COUGH (productive cough), MALAISE (feeling completely sick), PYREXIA (Fever) and NAUSEA (nausea) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced PYREXIA (Fever) and NAUSEA (nausea). On 07-Apr-2021, the patient experienced COVID-19 (Diagnosed with Covid-19). On 09-Apr-2021, the patient experienced PRODUCTIVE COUGH (productive cough) and MALAISE (feeling completely sick). The patient was treated with ALBUTEROL [SALBUTAMOL] on 09-Apr-2021 for Adverse event, at an unspecified dose and frequency; DOXYCYCLINE on 09-Apr-2021 for Adverse event, at an unspecified dose and frequency and PREDNISONE on 09-Apr-2021 for Adverse event, at an unspecified dose and frequency. On 11-Apr-2021, PRODUCTIVE COUGH (productive cough), MALAISE (feeling completely sick), PYREXIA (Fever) and NAUSEA (nausea) had resolved. At the time of the report, COVID-19 (Diagnosed with Covid-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment also included benzo-something (09-Apr-2021).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Eating disorder, Erythema, Facial pain, Mastication disorder, Oral pain
Clinical narrative: UTI; Whole face swelled down to her throat; Cheek bones sore; Hard time chewing; Couldn't eat; Mouth sore; Bright red; Itching; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URINARY TRACT INFECTION (UTI), SWELLING FACE (Whole face swelled down to her throat), FACIAL PAIN (Cheek bones sore), MASTICATION DISORDER (Hard time chewing) and EATING DISORDER (Couldn't eat) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced URINARY TRACT INFECTION (UTI), SWELLING FACE (Whole face swelled down to her throat), FACIAL PAIN (Cheek bones sore), MASTICATION DISORDER (Hard time chewing), EATING DISORDER (Couldn't eat), ORAL PAIN (Mouth sore), ERYTHEMA (Bright red) and PRURITUS (Itching). At the time of the report, URINARY TRACT INFECTION (UTI), SWELLING FACE (Whole face swelled down to her throat), FACIAL PAIN (Cheek bones sore), MASTICATION DISORDER (Hard time chewing), EATING DISORDER (Couldn't eat), ORAL PAIN (Mouth sore), ERYTHEMA (Bright red) and PRURITUS (Itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported.  Treatment medication included antihistamine.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Swelling face, Urinary tract infection
Clinical narrative: UTI; Whole face swelled down to her throat; Cheek bones sore; Hard time chewing; Couldn't eat; Mouth sore; Bright red; Itching; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URINARY TRACT INFECTION (UTI), SWELLING FACE (Whole face swelled down to her throat), FACIAL PAIN (Cheek bones sore), MASTICATION DISORDER (Hard time chewing) and EATING DISORDER (Couldn't eat) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced URINARY TRACT INFECTION (UTI), SWELLING FACE (Whole face swelled down to her throat), FACIAL PAIN (Cheek bones sore), MASTICATION DISORDER (Hard time chewing), EATING DISORDER (Couldn't eat), ORAL PAIN (Mouth sore), ERYTHEMA (Bright red) and PRURITUS (Itching). At the time of the report, URINARY TRACT INFECTION (UTI), SWELLING FACE (Whole face swelled down to her throat), FACIAL PAIN (Cheek bones sore), MASTICATION DISORDER (Hard time chewing), EATING DISORDER (Couldn't eat), ORAL PAIN (Mouth sore), ERYTHEMA (Bright red) and PRURITUS (Itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported.  Treatment medication included antihistamine.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Appetite disorder, Dehydration, Discomfort, Dyspnoea, Insomnia
Clinical narrative: Got panicky; Panic attack; could not breath; lungs felt heavy; no appetite, then a large appetite; felt dehydrated; soreness in arm; not feeling well; itching at a base of skull; rash on stomach; could not sleep; sore throat; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (could not breath), DISCOMFORT (lungs felt heavy), INSOMNIA (could not sleep), PANIC REACTION (Got panicky) and PANIC ATTACK (Panic attack) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037AZIB) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical history was provided by the reporter.  Concomitant products included ESTRADIOL (ESTROGEN), PROGESTERONE and MAGNESIUM for an unknown indication.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced INSOMNIA (could not sleep), OROPHARYNGEAL PAIN (sore throat), DEHYDRATION (felt dehydrated), PAIN IN EXTREMITY (soreness in arm), MALAISE (not feeling well), PRURITUS (itching at a base of skull) and RASH (rash on stomach). On 25-Apr-2021, the patient experienced DYSPNOEA (could not breath), DISCOMFORT (lungs felt heavy) and APPETITE DISORDER (no appetite, then a large appetite). On 26-Apr-2021, the patient experienced PANIC REACTION (Got panicky) and PANIC ATTACK (Panic attack). On 25-Apr-2021, DISCOMFORT (lungs felt heavy) had resolved. On 26-Apr-2021, PANIC REACTION (Got panicky) and PANIC ATTACK (Panic attack) had resolved. At the time of the report, DYSPNOEA (could not breath), INSOMNIA (could not sleep), OROPHARYNGEAL PAIN (sore throat), APPETITE DISORDER (no appetite, then a large appetite), DEHYDRATION (felt dehydrated), PAIN IN EXTREMITY (soreness in arm), MALAISE (not feeling well), PRURITUS (itching at a base of skull) and RASH (rash on stomach) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications included Valerian Root Tea , Magnesium
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Oropharyngeal pain, Pain in extremity, Panic attack, Panic reaction
Clinical narrative: Got panicky; Panic attack; could not breath; lungs felt heavy; no appetite, then a large appetite; felt dehydrated; soreness in arm; not feeling well; itching at a base of skull; rash on stomach; could not sleep; sore throat; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (could not breath), DISCOMFORT (lungs felt heavy), INSOMNIA (could not sleep), PANIC REACTION (Got panicky) and PANIC ATTACK (Panic attack) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037AZIB) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical history was provided by the reporter.  Concomitant products included ESTRADIOL (ESTROGEN), PROGESTERONE and MAGNESIUM for an unknown indication.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced INSOMNIA (could not sleep), OROPHARYNGEAL PAIN (sore throat), DEHYDRATION (felt dehydrated), PAIN IN EXTREMITY (soreness in arm), MALAISE (not feeling well), PRURITUS (itching at a base of skull) and RASH (rash on stomach). On 25-Apr-2021, the patient experienced DYSPNOEA (could not breath), DISCOMFORT (lungs felt heavy) and APPETITE DISORDER (no appetite, then a large appetite). On 26-Apr-2021, the patient experienced PANIC REACTION (Got panicky) and PANIC ATTACK (Panic attack). On 25-Apr-2021, DISCOMFORT (lungs felt heavy) had resolved. On 26-Apr-2021, PANIC REACTION (Got panicky) and PANIC ATTACK (Panic attack) had resolved. At the time of the report, DYSPNOEA (could not breath), INSOMNIA (could not sleep), OROPHARYNGEAL PAIN (sore throat), APPETITE DISORDER (no appetite, then a large appetite), DEHYDRATION (felt dehydrated), PAIN IN EXTREMITY (soreness in arm), MALAISE (not feeling well), PRURITUS (itching at a base of skull) and RASH (rash on stomach) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications included Valerian Root Tea , Magnesium
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Got panicky; Panic attack; could not breath; lungs felt heavy; no appetite, then a large appetite; felt dehydrated; soreness in arm; not feeling well; itching at a base of skull; rash on stomach; could not sleep; sore throat; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (could not breath), DISCOMFORT (lungs felt heavy), INSOMNIA (could not sleep), PANIC REACTION (Got panicky) and PANIC ATTACK (Panic attack) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037AZIB) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical history was provided by the reporter.  Concomitant products included ESTRADIOL (ESTROGEN), PROGESTERONE and MAGNESIUM for an unknown indication.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced INSOMNIA (could not sleep), OROPHARYNGEAL PAIN (sore throat), DEHYDRATION (felt dehydrated), PAIN IN EXTREMITY (soreness in arm), MALAISE (not feeling well), PRURITUS (itching at a base of skull) and RASH (rash on stomach). On 25-Apr-2021, the patient experienced DYSPNOEA (could not breath), DISCOMFORT (lungs felt heavy) and APPETITE DISORDER (no appetite, then a large appetite). On 26-Apr-2021, the patient experienced PANIC REACTION (Got panicky) and PANIC ATTACK (Panic attack). On 25-Apr-2021, DISCOMFORT (lungs felt heavy) had resolved. On 26-Apr-2021, PANIC REACTION (Got panicky) and PANIC ATTACK (Panic attack) had resolved. At the time of the report, DYSPNOEA (could not breath), INSOMNIA (could not sleep), OROPHARYNGEAL PAIN (sore throat), APPETITE DISORDER (no appetite, then a large appetite), DEHYDRATION (felt dehydrated), PAIN IN EXTREMITY (soreness in arm), MALAISE (not feeling well), PRURITUS (itching at a base of skull) and RASH (rash on stomach) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications included Valerian Root Tea , Magnesium
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Tingling in the left leg; Tingling in the right leg and; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in the right leg) and PARAESTHESIA (Tingling in the left leg) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No medical history was provided by the reporter. .  Concomitant products included MULTIVITAMINS [VITAMINS NOS] from 24-Apr-2021 to an unknown date for an unknown indication.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced PARAESTHESIA (Tingling in the right leg). On 18-Apr-2021, the patient experienced PARAESTHESIA (Tingling in the left leg). On 18-Apr-2021, PARAESTHESIA (Tingling in the right leg) outcome was unknown. On 26-Apr-2021, PARAESTHESIA (Tingling in the left leg) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment drugs were reported.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Chest discomfort, Decreased appetite, Dyspnoea, Hypersensitivity
Clinical narrative: shortness of breath; loss of appetite; Inflammation of legs, arms, stomach; loss of voice; Allergic Reaction; Chest Congestion; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), DECREASED APPETITE (loss of appetite), INFLAMMATION (Inflammation of legs, arms, stomach), APHONIA (loss of voice) and HYPERSENSITIVITY (Allergic Reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (shortness of breath), DECREASED APPETITE (loss of appetite), INFLAMMATION (Inflammation of legs, arms, stomach), APHONIA (loss of voice), HYPERSENSITIVITY (Allergic Reaction), CHEST DISCOMFORT (Chest Congestion) and NAUSEA (nausea). At the time of the report, DYSPNOEA (shortness of breath), DECREASED APPETITE (loss of appetite), INFLAMMATION (Inflammation of legs, arms, stomach), APHONIA (loss of voice), HYPERSENSITIVITY (Allergic Reaction), CHEST DISCOMFORT (Chest Congestion) and NAUSEA (nausea) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.    Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Nausea
Clinical narrative: shortness of breath; loss of appetite; Inflammation of legs, arms, stomach; loss of voice; Allergic Reaction; Chest Congestion; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), DECREASED APPETITE (loss of appetite), INFLAMMATION (Inflammation of legs, arms, stomach), APHONIA (loss of voice) and HYPERSENSITIVITY (Allergic Reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (shortness of breath), DECREASED APPETITE (loss of appetite), INFLAMMATION (Inflammation of legs, arms, stomach), APHONIA (loss of voice), HYPERSENSITIVITY (Allergic Reaction), CHEST DISCOMFORT (Chest Congestion) and NAUSEA (nausea). At the time of the report, DYSPNOEA (shortness of breath), DECREASED APPETITE (loss of appetite), INFLAMMATION (Inflammation of legs, arms, stomach), APHONIA (loss of voice), HYPERSENSITIVITY (Allergic Reaction), CHEST DISCOMFORT (Chest Congestion) and NAUSEA (nausea) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.    Reporter did not allow further contact
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect route of product administration, Limb discomfort, Vaccination site pain
Clinical narrative: felt like her arm was broken, still can't really use left arm; waves of pain like restless leg syndrome; it was given in the incorrect place on her arm; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (felt like her arm was broken, still can't really use left arm), VACCINATION SITE PAIN (waves of pain like restless leg syndrome) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (it was given in the incorrect place on her arm) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No medical history was reported.     On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced LIMB DISCOMFORT (felt like her arm was broken, still can't really use left arm), VACCINATION SITE PAIN (waves of pain like restless leg syndrome) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (it was given in the incorrect place on her arm). On 05-Apr-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (it was given in the incorrect place on her arm) had resolved. At the time of the report, LIMB DISCOMFORT (felt like her arm was broken, still can't really use left arm) and VACCINATION SITE PAIN (waves of pain like restless leg syndrome) outcome was unknown.            No concomitant medication history was reported.  The patient had an antibody test done and it was negative.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.  Treatment of the events included unspecified steroids.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Pain in extremity, Tenderness
Clinical narrative: Arm was Hurting; swollen lymph node on the collar bode; Pain in the lymph nodes; Tenderness under the armpits; This spontaneous case was reported by a consumer and describes the occurrence of LYMPH NODE PAIN (Pain in the lymph nodes), TENDERNESS (Tenderness under the armpits), PAIN IN EXTREMITY (Arm was Hurting) and LYMPHADENOPATHY (swollen lymph node on the collar bode) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Apr-2021, the patient experienced LYMPH NODE PAIN (Pain in the lymph nodes), TENDERNESS (Tenderness under the armpits) and LYMPHADENOPATHY (swollen lymph node on the collar bode). On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm was Hurting). At the time of the report, LYMPH NODE PAIN (Pain in the lymph nodes), TENDERNESS (Tenderness under the armpits) and LYMPHADENOPATHY (swollen lymph node on the collar bode) had not resolved and PAIN IN EXTREMITY (Arm was Hurting) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Expiration date and Event added
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Son missed his second Moderna vaccine that was scheduled for 4-19-2021; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Son missed his second Moderna vaccine that was scheduled for 4-19-2021) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Son missed his second Moderna vaccine that was scheduled for 4-19-2021). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Son missed his second Moderna vaccine that was scheduled for 4-19-2021) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.    Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow up information was received and contains no new information.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site discolouration, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: rash; pink around the injection site; warm at the injection site; itchy at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (pink around the injection site), VACCINATION SITE WARMTH (warm at the injection site), VACCINATION SITE PRURITUS (itchy at the injection site) and RASH (rash) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, the patient experienced VACCINATION SITE DISCOLOURATION (pink around the injection site), VACCINATION SITE WARMTH (warm at the injection site) and VACCINATION SITE PRURITUS (itchy at the injection site). On an unknown date, the patient experienced RASH (rash). At the time of the report, VACCINATION SITE DISCOLOURATION (pink around the injection site), VACCINATION SITE WARMTH (warm at the injection site), VACCINATION SITE PRURITUS (itchy at the injection site) and RASH (rash) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient stated that she received the second dose of vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Updated the outcome of all events.Added new event rash.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Mobility decreased, Pain
Clinical narrative: I felt so weak - husband had to help me to get around/ I have weakness/ husband had to help me to get around/ My husband had to support me to go to bathroom; I felt so achy; My husband had to support me to go to bathroom; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (I felt so weak - husband had to help me to get around/ I have weakness/ husband had to help me to get around/ My husband had to support me to go to bathroom), PAIN (I felt so achy) and MOBILITY DECREASED (My husband had to support me to go to bathroom) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Apr-2021, the patient experienced ASTHENIA (I felt so weak - husband had to help me to get around/ I have weakness/ husband had to help me to get around/ My husband had to support me to go to bathroom), PAIN (I felt so achy) and MOBILITY DECREASED (My husband had to support me to go to bathroom). At the time of the report, ASTHENIA (I felt so weak - husband had to help me to get around/ I have weakness/ husband had to help me to get around/ My husband had to support me to go to bathroom), PAIN (I felt so achy) and MOBILITY DECREASED (My husband had to support me to go to bathroom) outcome was unknown.            Action taken with response to the events are not applicable.   This case was linked to MOD-2021-090459 (Patient Link).
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Blue toe syndrome
Clinical narrative: Purplish blue to black odd spot on the middle 3 toes of the left foot; This spontaneous case was reported by a consumer and describes the occurrence of BLUE TOE SYNDROME (Purplish blue to black odd spot on the middle 3 toes of the left foot) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     Concomitant products included HCTZ, CLONAZEPAM, ELETRIPTAN, MECLIZINE HCL, ONDANSETRON (ZOFRAN [ONDANSETRON]), LISINOPRIL, PANTOPRAZOLE, SIMVASTATIN and ZOLPIDEM TARTRATE (ZOPIDEM) for an unknown indication, BUPROPION.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced BLUE TOE SYNDROME (Purplish blue to black odd spot on the middle 3 toes of the left foot). At the time of the report, BLUE TOE SYNDROME (Purplish blue to black odd spot on the middle 3 toes of the left foot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided by the reporter.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: missed 2nd vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (missed 2nd vaccine) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed 2nd vaccine). At the time of the report, PRODUCT DOSE OMISSION ISSUE (missed 2nd vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Feeling abnormal, Limb discomfort, Pain in extremity
Clinical narrative: not feeling well; arm is painful; arm is sore; can't move arm; chills; fever; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (not feeling well), PAIN IN EXTREMITY (arm is painful), PAIN IN EXTREMITY (arm is sore), LIMB DISCOMFORT (can't move arm) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, the patient experienced FEELING ABNORMAL (not feeling well), PAIN IN EXTREMITY (arm is painful), PAIN IN EXTREMITY (arm is sore), LIMB DISCOMFORT (can't move arm), CHILLS (chills), PYREXIA (fever) and ARTHRALGIA (joint pain). At the time of the report, FEELING ABNORMAL (not feeling well), PAIN IN EXTREMITY (arm is painful), PAIN IN EXTREMITY (arm is sore), LIMB DISCOMFORT (can't move arm), CHILLS (chills), PYREXIA (fever) and ARTHRALGIA (joint pain) outcome was unknown.            No concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: not feeling well; arm is painful; arm is sore; can't move arm; chills; fever; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (not feeling well), PAIN IN EXTREMITY (arm is painful), PAIN IN EXTREMITY (arm is sore), LIMB DISCOMFORT (can't move arm) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, the patient experienced FEELING ABNORMAL (not feeling well), PAIN IN EXTREMITY (arm is painful), PAIN IN EXTREMITY (arm is sore), LIMB DISCOMFORT (can't move arm), CHILLS (chills), PYREXIA (fever) and ARTHRALGIA (joint pain). At the time of the report, FEELING ABNORMAL (not feeling well), PAIN IN EXTREMITY (arm is painful), PAIN IN EXTREMITY (arm is sore), LIMB DISCOMFORT (can't move arm), CHILLS (chills), PYREXIA (fever) and ARTHRALGIA (joint pain) outcome was unknown.            No concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact